• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

FAECALIBACTERIUM PRAUSNITZII

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

IL23A DIABETES MELLITUS IL17A ANGIOGENESIS RECEPTOR INSULIN AGING TH17 CELLS TP53 INFLAMMATION BREAST CANCER AUTOPHAGY CTLA4 ALZHEIMER'S DISEASE REMICADE ESCHERICHIA COLI PSEUDOMONAS AERUGINOSA FOXP3 CANCER RHEUMATOID ARTHRITIS CELL DIFFERENTIATION DOXORUBICIN IL6 CD4 NEURODEGENERATIVE DISORDERS CLOSTRIDIUM DIFFICILE CANDIDA ALBICANS CELL DIVISION STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PNEUMONIAE ERBB-2 CASP3 CELL DEATH PORPHYROMONAS GINGIVALIS TNF 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL PROLIFERATION IMMUNE RESPONSE APOPTOTIC PROCESS HELICOBACTER PYLORI METFORMIN PARKINSON DISEASE LISTERIA MONOCYTOGENES IFNG SOD1

© 2019 Biovista Vizit All Rights Reserved.